Price | 1W % | 1M % | 3M % | 6M % | 1Y % | YTD % |
|---|---|---|---|---|---|---|
-- | -- | -- | -- | -- | -- | -- |
AI Generated Qualitative Analysis
Your time is precious, so save it. Use AI to get the most important information from the business.
Learn about OncoVista Innovative Therapies, Inc.
OncoVista Innovative Therapies, Inc. News
No news available
OncoVista Innovative Therapies, Inc. Quantitative Score
About OncoVista Innovative Therapies, Inc.
OncoVista Innovative Therapies, Inc., a biopharmaceutical company, develops targeted anticancer therapies by utilizing tumor-associated biomarkers. The company's product candidates include Cordycepin (OVI-123), which is in Phase I/II clinical trials for the treatment of refractory TdT positive leukemias; and L-Nucleoside Conjugates (OVI-117) that is under pre-clinical development for the treatment of colon cancer. The company was founded in 2004 and is based in San Antonio, Texas.
OncoVista Innovative Therapies, Inc. Earnings & Revenue
What’s This Company Really Worth? Find Out Instantly.
Warren Buffett’s go-to valuation method is Discounted Cash Flow (DCF). Our tool makes it effortless — no spreadsheets, just answers in a few clicks.
OncoVista Innovative Therapies, Inc. Financials
Table Compare
Compare OVIT metrics with: | |||
|---|---|---|---|
Earnings & Growth | OVIT | None | |
EPS (TTM) YoY Growth | -- | -- | |
Revenue (TTM) YoY Growth | -- | -- | |
Valuation (TTM) | OVIT | None | |
Price/Earnings Ratio | -- | -- | |
Price/Sales Ratio | -- | -- | |
Profitability & Efficiency (TTM) | OVIT | None | |
Net Profit Margin | -- | -- | |
Return on Equity | -- | -- | |
Financial Health (TTM) | OVIT | None | |
Debt/Assets Ratio | -- | -- | |
Assets/Liabilities Ratio | -- | -- | |
OncoVista Innovative Therapies, Inc. Income
OncoVista Innovative Therapies, Inc. Balance Sheet
OncoVista Innovative Therapies, Inc. Cash Flow
OncoVista Innovative Therapies, Inc. Financials Over Time
Historical Market Cap
Shares Outstanding
OncoVista Innovative Therapies, Inc. Executives
| Name | Role |
|---|---|
| Dr. Alexander L. Weis Ph.D. | Chairman, Chief Executive Officer, President, Chief Financial Officer, Principal Accounting Officer and Secretary |
| Name | Role | Gender | Date of Birth | Pay |
|---|---|---|---|---|
| Dr. Alexander L. Weis Ph.D. | Chairman, Chief Executive Officer, President, Chief Financial Officer, Principal Accounting Officer and Secretary | 1950 | 322K |